A recurrent mutation of tyrosine 641 (Y641) within the EZH2 SET domain has been detected in approximately 22% of diffuse large B-cell lymphoma (DLBCL) and 7% of follicular lymphomas (FL) [43]. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.